PATENT CLAIM ANALYSIS

Application Number: 15936927
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "023000"]

Abstract:
The invention relates to the treatment or prevention of renal impairment and/or complications using a SGLT-2 inhibitor, for example in patients diagnosed with metabolic disorders and related conditions.

Claim (Index 9):
Method according to  claim 1 , wherein the pharmaceutical composition comprises the SGLT-2 inhibitor in a range from about 10 mg to 25 mg.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13912599', '12673327', '13511771', '14048880', '12894385']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.776277904893442
- 35 USC 102 Novelty (BERT): 0.5305450863804624
- Combined Prediction Score: 0.751704623042144
- Mean Citation Score: 319.601472
- Max Citation Score: 352.47964
- Similarity Product: 248.15175794827945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test